FR2102082B2 - - Google Patents

Info

Publication number
FR2102082B2
FR2102082B2 FR7128797A FR7128797A FR2102082B2 FR 2102082 B2 FR2102082 B2 FR 2102082B2 FR 7128797 A FR7128797 A FR 7128797A FR 7128797 A FR7128797 A FR 7128797A FR 2102082 B2 FR2102082 B2 FR 2102082B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7128797A
Other versions
FR2102082A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prodotti Antibiotici SpA
Original Assignee
Prodotti Antibiotici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodotti Antibiotici SpA filed Critical Prodotti Antibiotici SpA
Publication of FR2102082A2 publication Critical patent/FR2102082A2/fr
Application granted granted Critical
Publication of FR2102082B2 publication Critical patent/FR2102082B2/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7128797A 1970-08-06 1971-08-05 Expired FR2102082B2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3802570A GB1356789A (en) 1970-08-06 1970-08-06 Derivatives of theophylline

Publications (2)

Publication Number Publication Date
FR2102082A2 FR2102082A2 (fr) 1972-04-07
FR2102082B2 true FR2102082B2 (fr) 1974-10-18

Family

ID=10400674

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7128797A Expired FR2102082B2 (fr) 1970-08-06 1971-08-05

Country Status (4)

Country Link
BE (1) BE771009R (fr)
ES (1) ES393934A2 (fr)
FR (1) FR2102082B2 (fr)
GB (1) GB1356789A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641783A (en) * 1993-11-12 1997-06-24 Cell Therapeutics, Inc. Substituted amino alcohol compounds
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
RU2764243C2 (ru) 2017-09-22 2022-01-14 ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи Гетероциклические соединения в качестве ингибиторов PAD
PT3697785T (pt) 2017-10-18 2023-04-03 Jubilant Epipad LLC Compostos de imidazopiridina como inibidores de pad
KR20200085836A (ko) 2017-11-06 2020-07-15 주빌런트 프로델 엘엘씨 Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
PT3704120T (pt) 2017-11-24 2024-07-03 Jubilant Episcribe Llc Compostos heterocíclicos como inibidores de prmt5
BR112020018610A2 (pt) 2018-03-13 2020-12-29 Jubilant Prodel LLC Compostos de fórmula i, fórmula ii, fórmula iii, fórmula iv, fórmula v, fórmula vi, ou seus polimorfos, estereoisômeros, tautômeros, profármacos, solvatos e sais farmaceuticamente aceitáveis dos mesmos e uso dos mesmos; processo de preparação; composição farmacêutica; e método para o tratamento e/ou prevenção de várias doenças, que incluem câncer e doenças infecciosas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (fr) * 1968-12-10 1971-05-05

Also Published As

Publication number Publication date
BE771009R (fr) 1971-12-16
FR2102082A2 (fr) 1972-04-07
ES393934A2 (es) 1974-02-16
GB1356789A (en) 1974-06-12

Similar Documents

Publication Publication Date Title
AU1473870A (fr)
AU2044470A (fr)
AU2085370A (fr)
AU1326870A (fr)
AU1336970A (fr)
AU1517670A (fr)
AU1716970A (fr)
AU1833270A (fr)
AU2017870A (fr)
AU1969370A (fr)
AU1841070A (fr)
AU1235770A (fr)
AU2144270A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU2130570A (fr)
AU2119370A (fr)
AU2115870A (fr)
AU2112570A (fr)
AU1247570A (fr)
AU2061170A (fr)
AU1277070A (fr)
AU1789870A (fr)
AU1974970A (fr)
AU1581370A (fr)